How often should thyroid labs be rechecked?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
Recheck TSH 6 to 8 weeks after starting levothyroxine or changing the dose, as the FDA label directs. Once stable, most people need testing every 6 to 12 months. Pregnancy is different: test as soon as pregnancy is confirmed and roughly every 4 weeks through the first half.
Thyroid testing intervals are set by how long the system takes to reach a new steady state, not by how a person feels. Levothyroxine has a long half-life, so a TSH drawn too early reflects the old dose more than the new one. The prescribing information instructs monitoring serum TSH 6 to 8 weeks after any change in dose, and adjusting in 12.5 to 25 mcg increments every 4 to 6 weeks until the patient is clinically euthyroid.
After starting or changing a dose
Six to eight weeks is the interval that matters most and the one most often shortened. Testing at three weeks catches a value that is still moving, which frequently triggers a dose change that was never needed, followed by another early test and another change. If a laboratory error or a symptom of over-replacement is suspected, that is a different situation and warrants earlier testing, but routine titration should hold the interval.
Once the dose is stable
The National Institute of Diabetes and Digestive and Kidney Diseases describes blood tests 6 to 8 weeks after starting levothyroxine, then every 6 months after a dose is settled, then annually. Testing more often than that on an unchanged dose rarely produces useful information and usually produces unnecessary adjustment, since TSH varies within an individual from day to day and by time of day.
When to test sooner than scheduled
Certain events change requirement enough to justify an off-schedule check: pregnancy, starting or stopping oestrogen therapy, significant weight change, starting a proton pump inhibitor or a calcium or iron supplement, starting carbamazepine, phenytoin or rifampicin, a pharmacy switch to a different manufacturer, and new symptoms of over-replacement such as palpitations, tremor or insomnia.
| Situation | When to check TSH |
|---|---|
| Starting levothyroxine or changing dose | 6 to 8 weeks later |
| Stable dose, no symptoms | Every 6 to 12 months |
| Positive TPO antibodies, normal thyroid function | About annually, sooner if symptoms or pregnancy |
| Pregnancy confirmed | Immediately, then about every 4 weeks in the first half |
| New interfering medication or supplement | 6 weeks after the change |
| Manufacturer or formulation switch | 6 weeks after the switch |
Book the follow-up blood test at the same visit where the dose changes, so the interval is set correctly rather than left to memory. Draw the sample before your morning levothyroxine dose and at a similar time of day each occasion, and use the same laboratory where you can.
The clinical detail
The 6 to 8 week interval reflects roughly five half-lives of levothyroxine plus the additional lag in pituitary TSH response. Sampling before the morning dose avoids the transient free T4 peak two to four hours after ingestion, which matters more on liothyronine or desiccated thyroid where a post-dose T3 peak suppresses TSH.
In pregnancy, the 2026 American Thyroid Association guideline advises thyroid function testing at pregnancy confirmation and approximately every 4 weeks during the first half of pregnancy. The National Institute of Diabetes and Digestive and Kidney Diseases describes testing every 4 to 6 weeks in the first half and at least once after 30 weeks. After thyroidectomy or radioiodine, test at 6 to 8 weeks and then at increasing intervals as the dose stabilises. Free T4 is added to TSH where central hypothyroidism, non-adherence or recent dose change makes TSH alone uninterpretable.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Levothyroxine Sodium Tablets Prescribing Information. U.S. Food and Drug Administration
- Hypothyroidism (Underactive Thyroid). National Institute of Diabetes and Digestive and Kidney Diseases
- American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. American Thyroid Association. PMID 42219800
- Hypothyroidism (Underactive Thyroid). American Thyroid Association
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.